1AD 0.00% 2.5¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-51

  1. 3,319 Posts.
    lightbulb Created with Sketch. 344
    I am interested to know how they will obtain capital to proceed with trials of all these clinical stage assests. Is SYNBV going to raise capital? Because there is no way Adalta can raise anything substantial at these levels.
    Last edited by asx11: 09/04/24
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
0.000(0.00%)
Mkt cap ! $14.89M
Open High Low Value Volume
2.5¢ 2.5¢ 2.5¢ $850 34K

Buyers (Bids)

No. Vol. Price($)
4 2294371 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 687066 3
View Market Depth
Last trade - 10.00am 19/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.